• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Killing two birds with one stone: response to pembrolizumab in a patient with metastatic melanoma and B-cell chronic lymphocytic leukaemia.

作者信息

Arenbergerova M, Fialova A, Arenberger P, Gkalpakiotis S, Jirasek T, Srp A, Novotna A, Frankova H

机构信息

Department of Dermatovenereology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.

Department of Pathology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.

出版信息

J Eur Acad Dermatol Venereol. 2018 Feb;32(2):e72-e74. doi: 10.1111/jdv.14537. Epub 2017 Sep 14.

DOI:10.1111/jdv.14537
PMID:28833722
Abstract
摘要

相似文献

1
Killing two birds with one stone: response to pembrolizumab in a patient with metastatic melanoma and B-cell chronic lymphocytic leukaemia.一石二鸟：帕博利珠单抗治疗转移性黑色素瘤合并B细胞慢性淋巴细胞白血病患者的疗效
J Eur Acad Dermatol Venereol. 2018 Feb;32(2):e72-e74. doi: 10.1111/jdv.14537. Epub 2017 Sep 14.
2
Coincident Metastatic Melanoma and Merkel Cell Carcinoma with Complete Remission on Treatment with Pembrolizumab.同时发生的转移性黑色素瘤和默克尔细胞癌经派姆单抗治疗后完全缓解
Acta Derm Venereol. 2017 Nov 15;97(10):1252-1254. doi: 10.2340/00015555-2757.
3
Pembrolizumab (Keytruda°) and metastatic or inoperable melanoma.帕博利珠单抗（可瑞达°）与转移性或不可切除的黑色素瘤
Prescrire Int. 2017 May;26(182):118-119.
4
Persistence of superficial basal cell carcinoma during pembrolizumab treatment for metastatic melanoma.帕博利珠单抗治疗转移性黑色素瘤期间浅表基底细胞癌持续存在。
Eur J Dermatol. 2021 Feb 1;31(1):99-100. doi: 10.1684/ejd.2020.3958.
5
Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial.在一项 II 期临床试验中，接受派姆单抗治疗的有活性脑转移的黑色素瘤患者的长期生存情况。
J Clin Oncol. 2019 Jan 1;37(1):52-60. doi: 10.1200/JCO.18.00204. Epub 2018 Nov 8.
6
[Treating metastatic melanoma: Risk management].[治疗转移性黑色素瘤：风险管理]
Ann Dermatol Venereol. 2017 Jan;144(1):3-5. doi: 10.1016/j.annder.2016.12.001. Epub 2017 Jan 4.
7
An Unusual Case of Synchronous Metastatic Melanomas With Differing Response to Pembrolizumab.一例对帕博利珠单抗反应不同的同步转移性黑色素瘤罕见病例。
J Oncol Pract. 2019 Mar;15(3):159-160. doi: 10.1200/JOP.18.00570.
8
A Retrospective Analysis of the Efficacy of Pembrolizumab in Melanoma Patients With Brain Metastasis.帕博利珠单抗治疗黑色素瘤脑转移患者疗效的回顾性分析
J Immunother. 2017 Apr;40(3):108-113. doi: 10.1097/CJI.0000000000000159.
9
Vitiligo-like lesions located over In-transit metastases of malignant melanoma as a clinical marker of complete response to pembrolizumab.恶性黑色素瘤皮下转移灶处出现的白癜风样皮损作为帕博利珠单抗完全缓解的临床标志物。
Dermatol Online J. 2019 Dec 15;25(12):13030/qt8d3818j5.
10
Definite regression of cutaneous melanoma metastases upon addition of topical contact sensitizer diphencyprone to immune checkpoint inhibitor treatment.在免疫检查点抑制剂治疗中加入外用接触致敏剂二苯环丙烯酮后，皮肤黑色素瘤转移灶出现明确的消退。
Exp Dermatol. 2016 Jul;25(7):553-4. doi: 10.1111/exd.13030.

引用本文的文献

1
The impact of immune checkpoint inhibitors in patients with chronic lymphocytic leukemia (CLL): A protocol for a systematic review and meta-analysis of randomized controlled trials.免疫检查点抑制剂对慢性淋巴细胞白血病（CLL）患者的影响：一项关于随机对照试验的系统评价和荟萃分析方案
Medicine (Baltimore). 2020 Jul 10;99(28):e21167. doi: 10.1097/MD.0000000000021167.
2
Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors.通过免疫疗法应对癌症耐药性：PD-1/PD-L1抑制剂的最新临床疗效与安全性
Cancers (Basel). 2018 Jan 25;10(2):32. doi: 10.3390/cancers10020032.